Yoko Takahashi
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 08, 2025
Safety of iGlarLixi in Japanese People with Type 2 Diabetes: A Post-marketing Database Study.Hideaki Kaneto, Makiko Hatanaka, Yukiko Morimoto
|Sep 30, 2024
Quality of Life in Japanese People with Type 2 Diabetes Switching from Multiple Daily Insulin Injections to Once-Daily iGlarLixi: SIMPLIFY Japan.Hitoshi Ishii, Hideki Kamiya, Yoko Takahashi
|Feb 16, 2024
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan.Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi
|Feb 22, 2023
Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study.Hideaki Miyoshi, Munehide Matsuhisa, Daisuke Yabe
|Nov 24, 2022
Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study.Munehide Matsuhisa, Hideaki Miyoshi, Daisuke Yabe
|Oct 07, 2022
Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL).Hideaki Kaneto, Mike Baxter, Yoko Takahashi
Pageof 1
